CN120202212A - 一种多肽抑制剂、其制备方法和应用 - Google Patents
一种多肽抑制剂、其制备方法和应用 Download PDFInfo
- Publication number
- CN120202212A CN120202212A CN202380079192.7A CN202380079192A CN120202212A CN 120202212 A CN120202212 A CN 120202212A CN 202380079192 A CN202380079192 A CN 202380079192A CN 120202212 A CN120202212 A CN 120202212A
- Authority
- CN
- China
- Prior art keywords
- amino acids
- alkyl
- integer
- added
- dmf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211530438 | 2022-11-30 | ||
| CN2022115304381 | 2022-11-30 | ||
| CN2023102062995 | 2023-03-03 | ||
| CN202310206299 | 2023-03-03 | ||
| CN202310261818 | 2023-03-15 | ||
| CN2023102618188 | 2023-03-15 | ||
| CN202310349519 | 2023-03-31 | ||
| CN202310349519X | 2023-03-31 | ||
| CN2023111444895 | 2023-09-05 | ||
| CN202311144489 | 2023-09-05 | ||
| PCT/CN2023/135637 WO2024114762A1 (zh) | 2022-11-30 | 2023-11-30 | 一种多肽抑制剂、其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN120202212A true CN120202212A (zh) | 2025-06-24 |
Family
ID=91323029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380079192.7A Pending CN120202212A (zh) | 2022-11-30 | 2023-11-30 | 一种多肽抑制剂、其制备方法和应用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20260193294A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4628499A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025540765A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250111134A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120202212A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023404553A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL321139A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025006152A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202440611A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024114762A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025242221A1 (zh) * | 2024-05-24 | 2025-11-27 | 上海翰森生物医药科技有限公司 | 新型修饰侧链、其制备方法和应用 |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026052109A1 (zh) * | 2024-09-06 | 2026-03-12 | 上海翰森生物医药科技有限公司 | 一种多肽抑制剂的药物组合物及其用途 |
| WO2026057052A1 (zh) * | 2024-09-14 | 2026-03-19 | 深圳信立泰药业股份有限公司 | 一种il-23受体抑制剂及其制备方法和用途 |
| WO2026138829A1 (zh) * | 2024-12-23 | 2026-07-02 | 上海医药集团股份有限公司 | 多肽抑制剂及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201810154WA (en) * | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| EP4021919A1 (en) | 2019-08-30 | 2022-07-06 | Merck Sharp & Dohme Corp. | Pcsk9 antagonist compounds |
| US12577259B2 (en) | 2019-12-20 | 2026-03-17 | Merck Sharp & Dohme Llc | PCSK9 antagonist compounds |
| MX2022008740A (es) * | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| SMT202500254T1 (it) * | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
| AU2021383828A1 (en) * | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
-
2023
- 2023-11-30 WO PCT/CN2023/135637 patent/WO2024114762A1/zh not_active Ceased
- 2023-11-30 AU AU2023404553A patent/AU2023404553A1/en active Pending
- 2023-11-30 US US19/133,875 patent/US20260193294A1/en active Pending
- 2023-11-30 KR KR1020257019116A patent/KR20250111134A/ko active Pending
- 2023-11-30 TW TW112146695A patent/TW202440611A/zh unknown
- 2023-11-30 JP JP2025531331A patent/JP2025540765A/ja active Pending
- 2023-11-30 IL IL321139A patent/IL321139A/en unknown
- 2023-11-30 CN CN202380079192.7A patent/CN120202212A/zh active Pending
- 2023-11-30 EP EP23896904.2A patent/EP4628499A1/en active Pending
-
2025
- 2025-05-27 MX MX2025006152A patent/MX2025006152A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL321139A (en) | 2025-07-01 |
| JP2025540765A (ja) | 2025-12-16 |
| MX2025006152A (es) | 2025-07-01 |
| US20260193294A1 (en) | 2026-07-09 |
| AU2023404553A1 (en) | 2025-07-10 |
| TW202440611A (zh) | 2024-10-16 |
| WO2024114762A1 (zh) | 2024-06-06 |
| KR20250111134A (ko) | 2025-07-22 |
| EP4628499A1 (en) | 2025-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI862640B (zh) | 異質雙環肽複合物 | |
| KR20250111134A (ko) | 폴리펩티드 억제제, 이의 제조 방법 및 응용 | |
| US20240148916A1 (en) | Bivalent fibroblast activation protein ligands for targeted delivery applications | |
| US20240352073A1 (en) | Bicyclic peptide inhibitors of interleukin-23 receptor | |
| WO2020259258A1 (zh) | 一种抗体偶联药物、其中间体、制备方法及应用 | |
| CZ285104B6 (cs) | Deriváty kyseliny žlučové, způsob jejich přípravy a použití těchto sloučenin jako léčiv | |
| US20110301087A1 (en) | Crf1 receptor compounds | |
| JPH06503090A (ja) | ノナペプチドのボンベシン拮抗薬 | |
| TW202327620A (zh) | 一種抗炎症的化合物及其用途 | |
| TW202435884A (zh) | 用於抑制tnf受體1活性之環狀肽 | |
| CN120390747A (zh) | 用于靶向递送应用的碳酸酐酶ix配体 | |
| CN112851755B (zh) | 一种线性脂肽化合物及其制备方法与应用 | |
| SCHULTZ et al. | Synthesis and conformational properties of a synthetic cyclic peptide for the active site of α‐chymotrypsin | |
| CA2061993A1 (en) | Fucose-bearing cytostatics | |
| TW201536815A (zh) | 血管加壓素-2受器促效劑 | |
| CN114634551B (zh) | 多肽及其在制备拮抗野生型p53与MDM2结合的抗癌药物中的应用 | |
| RU2800137C1 (ru) | Конъюгат антитело-лекарственное средство, промежуточное соединение для его получения, способ его получения и его применение | |
| EP4471049A1 (en) | Peptide inhibitors of interleukin-23 receptor | |
| EP4471048A1 (en) | Peptide inhibitors of interleukin-23 receptor | |
| CN109415378B (zh) | 水溶性Epothilone衍生物及其制备方法 | |
| WO2023088236A1 (zh) | Mt1-mmp的双环肽配体及其缀合物 | |
| EP4652182A1 (en) | Peptide inhibitors of interleukin-23 receptor | |
| JPS6110553A (ja) | プロリン誘導体 | |
| CA3191963A1 (en) | Thionoester-derivative of rabeximod for the treatment of inflammatory and autoimmune disorders | |
| JPH0482899A (ja) | ペプチドまたはその塩およびそれらを含有する甲状腺機能亢進症の診断薬または治療薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40124253 Country of ref document: HK |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |